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Seasonal affective disorder or SAD is a recurrent major depressive disorder with a seasonal pattern usually beginning in fall and
continuing into winter months. A subsyndromal type of SAD, or S-SAD, is commonly known as “winter blues.” Less often, SAD
causes depression in the spring or early summer. Symptoms center on sad mood and low energy. Those most at risk are female, are
younger, live far from the equator, and have family histories of depression, bipolar disorder, or SAD. Screening instruments include
the Seasonal Pattern Assessment Questionnaire (SPAQ). Typical treatment includes antidepressant medications, light therapy,
Vitamin D, and counselling. This paper provides an overview of SAD.
1. Introduction
As sunlight decreases during the short dark days of winter,
many individuals struggle with seasonal affective disorder
or SAD. As the acronym so aptly illustrates, those afflicted
experience feelings of sadness and loss of energy, especially
during December, January, and February, around the winter
solstice, when the days are shortest. Existing research has
focused on the key treatment approaches of antidepressant
medication, light therapy, Vitamin D, and counselling. This
paper presents an overview of SADby explaining the disorder
and commenting on treatment approaches.
2. An Explanation of Seasonal
Affective Disorder (SAD)
2.1. What Is SAD? Seasonal affective disorder or SAD is
not considered a unique diagnostic entity. Rather, it is a
type of recurring major depression with a seasonal pattern.
According to the Diagnostic and Statistical Manual of Mental
Disorders DSM-5 [1], criteria for depression with a seasonal
pattern include having depression that begins and ends
during a specific season every year (with full remittance
during other seasons) for at least two years and having more
seasons of depression than seasons without depression over
a lifetime. Seasonal pattern disorders occur most frequently
in winter although they can also occur in summer.
People with seasonal affective disorder have difficulty
regulating the neurotransmitter serotonin, a neurotransmit-
ter believed to be responsible for balancing mood [2]. In
one study, people with SAD had 5% more SERT, a protein
that assists with serotonin transport, in the winter months
than in summer [2]. SERT transports serotonin from the
synaptic cleft to the presynaptic neuron, so higher SERT
levels lead to lower serotonin activity, thus causing depression
[2]. Throughout the summer, sunlight generally keeps SERT
levels naturally low [2]. But as sunlight diminishes in the fall,
a corresponding decrease in serotonin activity also occurs.
People with SAD may also have difficulty with overpro-
duction of melatonin [3]. Melatonin is a hormone produced
by the pineal gland that responds to darkness by causing
sleepiness [4]. As winter days become darker, melatonin
production increases and, in response, those with SAD feel
sleepy and lethargic [5]. Although melatonin likely plays a
role in impacting the symptoms of SAD, it cannot by itself
account for these phenomena [6].
The combination of decreased serotonin and increased
melatonin impacts circadian rhythms. Circadian rhythms
or the body’s internal 24-hour “clock” are synchronized to
respond to the rhythmic light–dark changes that occur daily
and throughout each of the seasons. For people with SAD,
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the circadian signal that indicates a seasonal change in day
length has been found to be timed differently, thus making it
more difficult for their bodies to adjust [7–9].
Further, with less outdoor exposure to sunlight on the
skin in winter, people with SAD may produce less Vitamin
D [10, 11]. As Vitamin D is believed to play a role in serotonin
activity, Vitamin D deficiency and insufficiency have been
associated with clinically significant depressive symptoms
[12, 13]. Causal links between serotonin, melatonin, circadian
rhythms, Vitamin D, and SAD have not yet been confirmed.
However, associations among these key factors are present
and are continuing to be researched.
2.1.1. Symptoms. Symptoms of winter seasonal pattern disor-
ders center on sadmood and low energy [14–18]. Information
for the lay public identify that people with SAD can feel
sad, irritable, and may cry frequently; and they are tired
and lethargic, have difficulty concentrating, sleep more than
normal, lack energy, decrease their activity levels, withdraw
from social situations, crave carbohydrates and sugars, and
tend to gain weight due to overeating [5, 19–21].
Conversely, in addition to irritability, symptoms of the
less frequently occurring summer seasonal pattern disorder
center on poor appetitewith associatedweight loss, insomnia,
agitation, restlessness, anxiety, and even episodes of violent
behavior [22, 23]. It is important to note that seasonal pattern
disorders vary in severity. Some individuals may experience
a milder form of SAD known as subsyndromal S-SAD [24–
26], or most commonly as “winter blues.” However, others
can be severely incapacitated and unable to function. In
some instances, symptoms of SAD can be as severe as those
experienced by in-patients with nonseasonal depression [27,
28]. Like all depressive disorders, thoughts of suicide may be
present [29, 30]. Health professionals must always implement
suicide assessments with people they believe have or might
have SAD.
2.1.2. History. Although low mood and low energy levels
during the short dark days of winter may have always been
an expected part of life for those living far from the equator,
they were first identified as a treatable clinical condition
during the 1980s [31–34].When physicianNormanRosenthal
moved to the United States from his native South Africa, he
noticed that he felt much less productive in the winter but
returned to normal as soon as spring arrived [35]. In his
work at the National Institutes of Health, NIH, in the US,
Rosenthal collaborated with Al Lewy, who was researching
melatonin, and with Tom Wehr who was researching how
light suppressed melatonin and impacted circadian rhythms.
Together, they applied and disseminated their findings about
how bright light could effectively treat patients with SAD
[31]. The notion of SAD as a depressive condition warranting
further study resonated with many who live in northern lat-
itudes and is now a common and well-documented disorder
[36].
2.1.3. Prevalence. Seasonal affective disorder occurs four
times more often in women than in men and the age of
onset is estimated to be between 18 and 30 years [35]. Those
living farthest from the equator in northern latitudes aremost
susceptible [37]. For example, in theUnited States, 1% of those
who live in Florida and 9%who live inAlaska experience SAD
[38]. InCanada 15%of the population experiencewinter blues
and 2 to 6% experience SAD [39]. In the United Kingdom,
20% experiencewinter blues and 2% experience SAD [40, 41].
Pinpointing prevalence is difficult as the disorder may go
unreported and consequently underdiagnosed [42]. SAD can
cooccur with other depressive, bipolar, attention deficit, alco-
holism, and eating disorders, making it difficult to diagnose
[43]. As people with SAD may also have subtle decreases in
thyroid function, their hypothyroidism can mask symptoms
of SAD [44]. Given that SAD is a disorder women often
experience and one that is triggered by limited exposure to
sunlight, nurses and other health professionals who do shift
work may be at particular risk [45].
2.2. Seasonal Pattern Assessment Questionnaire (SPAQ).
Clearly a significant number of people are living with the
debilitating effects of SADand are not functioning to their full
potential. By screening for SAD and S-SAD, particularly in
familiar primary care settingswhere clients are accustomed to
coming for treatment, health professionals can help identify
those who are suffering [46].
The Seasonal Pattern Assessment Questionnaire (SPAQ)
first developed by Rosenthal and colleagues in 1984 [47]
continues to be widely used [31, 48, 49]. The SPAQ is
a retrospective, self-administered tool that screens for the
existence of SAD and S-SAD. It is freely available in the public
domain and can be downloaded from http://www.guilford
.com/add/forms/rosenthal2.pdf. No training is required to
use the tool.
2.2.1. Scoring the SPAQ. Scoring the SPAQ is not straightfor-
ward and clinicians and researchers use the tool in different
ways. Questions two and three provide particularly useful
information in that they yield a specific number on the
Global Seasonality Score or GSS [49–51]. This number or
score can immediately communicate whether SAD or S-SAD
is likely present and the degree of severity. As such, health
professionals can use these two questions to add GSS to their
client/patient assessments.
In question two, respondents rate their sleep length, social
activity, mood, weight, appetite, and energy level on Likert
scales scored from 0 to 4. In question three, respondents
rate the degree that seasonal changes are a “problem” (mild,
moderate, marked, severe, or disabling).
A GSS of 11 or above and a problem rating of at least
moderate are indicative of SAD. A GSS of 9 or 10 and a
problem rating of at least mild are indicative of S-SAD.
2.2.2. Reliability, Validity, and Specificity. The SPAQ has been
demonstrated to be reliable in that it measures consistently
and to be valid in that it measures what it was designed
to measure [49, 51–53]. However, it has been criticized for
having low specificity, meaning that results may suggest
people who do not have SAD will score as though they
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do [48]. This low specificity may misclassify people with
nonseasonal depressions.This misclassification could in turn
indicate misleadingly high estimates of prevalence [42, 54].
3. Treatment Approaches
Treatment approaches typically include combinations of
antidepressant medication, light therapy, Vitamin D, and
counselling.The next section provides a brief outline of these.
3.1. Antidepressant Medications. SAD, like other depressions,
is believed to be associated with a dysfunction in brain sero-
tonin activity. Therefore, second generation antidepressants
(SGAs), such as the Selective Serotonin Reuptake Inhibitors
(SSRIs), particularly fluoxetine (Prozac), have emerged as
promising antidepressant medication treatments [55–57]. In
the seminal Canadian study comparing the effectiveness of
fluoxetine and light therapy in SAD (Can-Sad), fluoxetinewas
found to be as effective and as well-tolerated as light therapy
and it was more cost-effective [58].
Bupropion (Wellbutrin), another SGASSRI, has also been
widely promoted as an effective medication for treating SAD
[59–61]. In the northern US and Canada, one study revealed
that beginning bupropion XL 150–300mg daily early in the
season while people were still well did prevent recurrence of
seasonal depressive episodes [62].
With any medication treatment, it is important to draw
attention to the issue of adverse effects. A Cochrane review of
second generation antidepressants (SGAs) and SAD empha-
sized that insufficient evidence exists to come to any overall
conclusions on the use of SGAs for SAD; and the authors
noted that up to 27% of participants treated with SGAs
for SAD withdrew from the studies early due to adverse
effects [63].Therefore, although antidepressant medication is
a viable and often convenient treatment for SAD, especially
for those whose symptoms are incapacitating, other options
should also be considered.
3.2. Light Therapy. Knowing the difference decreased day-
light can make in triggering SAD and S-SAD, approaches
seeking to replace the diminished sunshine using bright
artificial light, particularly in the morning, have consistently
showed promise [31, 33, 43, 58, 64–67]. Light therapy is also
referred to as Bright Light Therapy (BLT) or phototherapy.
Light boxes can be purchased that emit full spectrum light
similar in composition to sunlight. Symptoms of SAD and S-
SAD may be relieved by sitting in front of a light box first
thing in the morning, from the early fall until spring [68].
In the Scandinavian countries, light rooms, where light is
indirect and evenly distributed, are available [66]. Typically
light boxes filter out ultraviolet rays and require 20–60
minutes of exposure to 10,000 lux of cool-white fluorescent
light daily during fall and winter [67]. This is about 20 times
as great as ordinary indoor lighting [38].
Adverse effects of light therapy are usually less severe
than those associated with antidepressants. They include
eyestrain, increased risk of age-relatedmacular degeneration,
headaches, irritability, and difficulty sleeping [5]. Ocular
changes and abnormalities are not associated with light
therapy [69]. Light therapy should not be used in conjunction
with photosensitizing medications such as lithium, mela-
tonin, phenothiazine antipsychotics, and certain antibiotics
[69]. In some cases, hypomania and suicidal ideation may
occur, especially during the first few days of treatment
[70]. Light therapy use should be monitored by a health
professional [71].
3.3. Vitamin D. A systematic review and meta-analysis con-
cluded that low levels of Vitamin D are associated with
depression [10]. Vitamin D concentration is assessed by
serum 25-hydroxyvitamin D (25-OH D) levels: with optimal
levels at 30 nq/mL; insufficient levels at less than 30 ng/mL;
deficient levels at less than 20 ng/mL; and intoxication levels
at greater than 150 nq/mL [72]. Low levels of Vitamin D are
usually due to insufficient dietary intake or lifestyle issues
such as little outdoor exposure to sunshine [11]. During the
winter months of November through February, those living
about 33 degrees north or 30 degrees south of the equator are
not able to synthesize Vitamin D [73].
Many people with SAD and S-SAD have insufficient
or deficient levels of Vitamin D, and although no further
studies have confirmed the findings, research investigating
this association suggests that taking 100,000 IU daily may
improve their symptoms [74, 75]. Taking Vitamin D before
winter darkness sets in may help prevent symptoms of
depression [12]. Adverse reactions or intoxication is rare but
could occur from doses of more than 50,000 IU per day [72].
3.4. Counselling. Counselling approaches can provide help
and support to people with SAD. In one study, six weeks
of Cognitive Behavioral Therapy (CBT) provided in group
format during two 90-minute sessions per week was as
effective as 30 minutes of 10,000 lux of cool-white fluorescent
light each morning [76]. An overarching goal of CBT is to
break down problems that seem overwhelming and negative
patterns by changing the way people think about them [5].
Other forms of counselling for SAD and S-SAD integrate
elements of CBT by providing new ways of thinking about
sad mood and low energy. When depressive symptoms are
not severe, programs that help people improve their diet by
limiting starches and sugars; increase their exercise; manage
their stress; avoid social withdrawal; and spend more time
outdoors are all recommended [5].
On his website, Norman Rosenthal encourages self-
counselling by finding ways to reduce the stress that
inevitably accompanies the incapacitating symptoms of SAD.
He found that Transcendental Meditation (TM), other forms
of mindfulness, yoga, walking, and exercise that is personally
enjoyable were beneficial [35]. Rosenthal advocates a diet
high in proteins, vegetables, unprocessed foods, and complex
carbohydrates. He also suggests planning winter trips to
sunny locales before winter sets in and people lack the
motivation to do so [35].
As the preceding sections explained, SAD is a disorder
precipitated by lack of needed exposure to sunlight. Further,
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most SAD treatment approaches, the exception being antide-
pressant medications and counselling, are based on increas-
ing people’s exposure to bright light. Health professionals
can play a critical role in supporting those who live with
SAD by seeking to understand the condition more deeply, to
integrate assessment tools such as SPAQ into their practice,
and to become aware of current evidence-based treatment
approaches.
4. Conclusion
In summary, this paper provided an overview of SAD and
S-SAD or the “winter blues,” explaining what the disorder
is in relation to DSM-5 criteria, symptoms, history, and
prevalence. People with SAD experience sad moods and
low energy to the extent that they are not able to function.
Those who live in northern latitudes are most at risk. The
self-reported Global Functioning Scores on the Seasonal
Pattern Assessment Questionnaire (SPAQ) can immediately
communicate people’s views about the severity of their illness.
Sunlight plays a critical role in the decreased serotonin
activity, increasedmelatonin production, disrupted circadian
rhythms, and low levels of Vitamin D associated with symp-
toms of SAD. Antidepressant medications offer some relief.
However, light therapy, Vitamin D supplements, and coun-
selling approaches are also emerging as effective treatments.
This paper calls for health professionals to integrate SAD
assessments and treatments into their practice, both with
themselves and with those they care about and for.
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